Psyence Biomedical Ltd. (PBM)’s stock is trading at $0.10 at the moment marking a rise of 4.56% from the last session close. As of this writing, shares are priced at -99.31% less than their 52-week high of $14.55, and 19.27% over their 52-week low of $0.08. Based on the past 30-day period, the stock price is -38.69% below the high and +11.47% above the low.
How does Psyence Biomedical Ltd. (PBM) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Psyence Biomedical Ltd. (NASDAQ: PBM) Ownership Details
I will give a breakdown of the key shareholders in Psyence Biomedical Ltd. (PBM). Recent figures show that the company’s insiders hold 17.59% of shares. A total of 13 institutional investors hold shares in the company, making 6.30% of its stock and 7.64% of its float.
Jun 30, 2024 , it was reported that the Company’s largest institutional holder is AdvisorShares Investments, LLC holding total of 463.04 shares that make 1.15% of the company’s total number of shares and are currently priced at 45285.0.
The securities firm Cantor Fitzgerald, L.P. holds 337.0 shares of PBM, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.84% , and the holding percentage of shares is valued at 32958.0.
An overview of Psyence Biomedical Ltd.’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Psyence Biomedical Ltd. (PBM) traded 7,258,407 shares per day, with a moving average of $0.1087 and price change of -0.0327. With the moving average of $0.2814 and a price change of -0.4557, about 4,168,917 shares changed hands on average over the past 50 days. Finally, PBM’s 100-day average volume is 3,577,125 shares, alongside a moving average of $0.4038 and a price change of -0.7545.
